240 related articles for article (PubMed ID: 3816879)
1. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration.
Jaillon P; Poirier JM; Lecocq B; Jarreau C; Pays M; Richard MO; Cheymol G
Eur J Drug Metab Pharmacokinet; 1986; 11(3):233-8. PubMed ID: 3816879
[TBL] [Abstract][Full Text] [Related]
2. The bioavailability and kinetics of dihydroquinidine in patients with heart disease.
Regazzi Bonora M; Salerno JA; Rondanelli R; Cristiani D; Chimienti M
Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of dihydroquinidine in congestive heart failure patients after intravenous quinidine administration.
Ueda CT; Dzindzio BS
Eur J Clin Pharmacol; 1979 Sep; 16(2):101-5. PubMed ID: 499305
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers.
Kramer WG; Nagabhushan N; Affrime MB; Perentesis GP; Symchowicz S; Patrick JE
J Clin Pharmacol; 1988 Jul; 28(7):644-8. PubMed ID: 3216030
[TBL] [Abstract][Full Text] [Related]
5. Absorption of quinidine and dihydroquinidine in humans.
Hailey DM; Lea AR; Coles DM; Heaume PE; Smith WJ
Eur J Clin Pharmacol; 1981; 21(3):195-9. PubMed ID: 7318878
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administration.
Lecocq B; Jaillon P; Lecocq V; Ferry A; Gardin ME; Jarreau C; Leroyer R; Pays M; Jarreau FX
J Cardiovasc Pharmacol; 1988 Oct; 12(4):445-50. PubMed ID: 2465445
[TBL] [Abstract][Full Text] [Related]
7. Disposition kinetics of dihydroquinidine following quinidine administration.
Ueda CT; Williamson BJ; Dzindzio BS
Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of quinidine and three of its metabolites in man.
Rakhit A; Holford NH; Guentert TW; Maloney K; Riegelman S
J Pharmacokinet Biopharm; 1984 Feb; 12(1):1-21. PubMed ID: 6747817
[TBL] [Abstract][Full Text] [Related]
9. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
[TBL] [Abstract][Full Text] [Related]
10. Absolute quinidine bioavailability.
Ueda CT; Williamson BJ; Dzindzio BS
Clin Pharmacol Ther; 1976 Sep; 20(3):260-5. PubMed ID: 954347
[TBL] [Abstract][Full Text] [Related]
11. Bioavailability of a commercial sustained-release quinidine tablet compared to oral quinidine solution.
Sawyer WT; Pulliam CC; Mattocks A; Foster J; Hadzija BW; Rosenthal HM
Biopharm Drug Dispos; 1982; 3(4):301-10. PubMed ID: 7159686
[TBL] [Abstract][Full Text] [Related]
12. Cefetamet pivoxil clinical pharmacokinetics.
Blouin RA; Stoeckel K
Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic studies of quinidine in patients with arrhythmias.
Conrad KA; Molk BL; Chidsey CA
Circulation; 1977 Jan; 55(1):1-7. PubMed ID: 830196
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and absolute bioavailability of diltiazem in humans.
Ochs HR; Knüchel M
Klin Wochenschr; 1984 Apr; 62(7):303-6. PubMed ID: 6727272
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans.
Koup JR; Dubach UC; Brandt R; Wyss R; Stoeckel K
Antimicrob Agents Chemother; 1988 Apr; 32(4):573-9. PubMed ID: 3377466
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of N-acetylcysteine in man.
Borgström L; Kågedal B; Paulsen O
Eur J Clin Pharmacol; 1986; 31(2):217-22. PubMed ID: 3803419
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations.
Bagli M; Rao ML; Höflich G; Kasper S; Langer M; Barlage U; Beneke M; Süverkrüp R; Möller HJ
Arzneimittelforschung; 1996 Mar; 46(3):247-50. PubMed ID: 8901143
[TBL] [Abstract][Full Text] [Related]
19. Bioavailability of repaglinide, a novel antidiabetic agent, administered orally in tablet or solution form or intravenously in healthy male volunteers.
Hatorp V; Oliver S; Su CA
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):636-41. PubMed ID: 9877000
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.
Greenblatt DJ; Pfeifer HJ; Ochs HR; Franke K; MacLaughlin DS; Smith TW; Koch-Weser J
J Pharmacol Exp Ther; 1977 Aug; 202(2):365-78. PubMed ID: 577934
[No Abstract] [Full Text] [Related]
[Next] [New Search]
